Artificial heart offers hope for transplant candidates

NCT ID NCT04475393

Ongoing Disease control Sponsor: Carmat SAS Source: ClinicalTrials.gov ↗

First seen Jan 28, 2026 · Last updated May 23, 2026 · Updated 13 times

Summary

This study is testing the Carmat Total Artificial Heart in 104 people with severe, irreversible heart failure who are waiting for a heart transplant. The device is designed to replace both heart chambers and keep patients alive until a donor heart becomes available. Researchers are measuring how many patients survive without major complications like disabling stroke or device failure for 180 days after implantation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED HEART FAILURE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

CHRU Montpellier

Montpellier, 34090, France
CHU Dijon

Dijon, 21000, France
Centre Hospitalier Régional Universitaire

Lille, 59000, France
Groupe Hospitalier Pitié-Salpêtrière,

Paris, 75013, France
Hôpital Européen George Pompidou

Paris, 75015, France
Hôpital Laennec

Nantes, 44093, France
Hôpital Louis Pradel

Bron, 69500, France
Hôpital Marie Lannelongue

Le Plessis-Robinson, 92350, France
Hôpital Pontchaillou

Rennes, 35033, France
Nouvel Hôpital Civil

Strasbourg, 67000, France

Conditions

Explore the condition pages connected to this study.

ADVANCED HEART FAILURE